Primary leiomyosarcoma of the breast is an extremely rare neoplasm accounting for less than 0.0006% of all breast malignancies, with fewer than 80 cases reported in the literature to date. Here, we present a case of leiomyosarcoma of the breast in a 61-year-old woman without traditional risk factors. This case was treated with lumpectomy requiring wide margins due to the high rate of local recurrence. A planned breast reduction surgery was deemed adequate postlumpectomy therapy to prevent cancer recurrence, negating the need for chemotherapy or radiation therapy. To our knowledge, this is the first case in which cosmetic breast reduction surgery will be used as postlumpectomy cancer recurrence risk mitigation for primary leiomyosarcoma of the breast. Patients with this malignancy have a relatively poor prognosis compared with other breast cancer types, with a 5-year disease-free survival of 33%-52%. As such, frequent follow-up and monitoring for postresection recurrence is essential.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705364PMC
http://dx.doi.org/10.1136/bcr-2020-236013DOI Listing

Publication Analysis

Top Keywords

leiomyosarcoma breast
16
primary leiomyosarcoma
12
breast reduction
12
reduction surgery
12
breast
9
cosmetic breast
8
cancer recurrence
8
rare case
4
case primary
4
leiomyosarcoma
4

Similar Publications

Background: The diagnosis of rare uterine leiomyosarcoma (uLMS) remains a challenge given the high incidence rates of benign uterine tumors such as leiomyoma (LM). In the last decade, several clinical scores and blood serum markers have been proposed. The aim of this study is to validate and update the pLMS clinical scoring system, evaluating the accuracy of the scoring system by Zhang et al.

View Article and Find Full Text PDF

Background: Budd-Chiari syndrome is a rare and severe vascular liver disease. We presented patient with fulminant liver failure secondary to leiomyosarcoma of the IVC and thrombosis.

Case Presentation: A 44-year-old female presented with fulminant liver failure secondary to inferior vena cava (IVC) thrombosis.

View Article and Find Full Text PDF
Article Synopsis
  • Soft tissue sarcomas (STSs) make up less than 1% of all malignant tumors in humans, and treatment for metastatic STSs focuses on palliative care due to poor prognosis.
  • A study evaluated the effectiveness of low-dose radiotherapy combined with metronomic therapy in 16 heavily treated patients with metastatic STSs, aiming to assess their response and quality of life.
  • Results showed that 43.75% of patients achieved a partial response, and all reported improved quality of life compared to their previous treatment, demonstrating potential benefits of this combined approach in managing STSs.
View Article and Find Full Text PDF

Tattoo complications: Neutrophilic dermatoses, viral and systemic fungal infections, and neoplasms.

J Am Acad Dermatol

November 2024

Department of Dermatology, University of California Davis Health, Sacramento, California; Touro University California College of Osteopathic Medicine, Vallejo, California; University of Florida College of Medicine, Maples Center for Forensic Medicine, Gainesville, Florida. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!